Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

As the Altria stock price remains near a critical technical level, does Altria stock have further to climb? Learn more about how you should approach Altria.

The One Question that Matters for Altria Stock

Altria's (MO) third-quarter 2022 results reflect an increase in earnings due to solid pricing. However, net revenues come in lower due to soft revenues from the smokeable product unit.

Altria (MO) Q3 Earnings Lag Estimates, Revenues Decline Y/Y

Altria Group, Inc. (NYSE:MO ) Q3 2022 Results Conference Call October 27, 2022 9:00 AM ET Company Participants Mac Livingston - Vice President of Investor Relations Billy Gifford - CEO Sal Mancuso - CFO Conference Call Participants Bonnie Herzog - Goldman Sachs Pamela Kaufman - Morgan Stanley Chris Growe - Stifel Gaurav Jain - Barclays Vivien Azer - Cowen Oliver Brotman - JPMorgan Callum Elliott - Bernstein Operator Good day, and welcome to the Altria Group 2022 Third Quarter and Nine Months Earnings Conference Call. Today's call is scheduled to last about one hour, including remarks by Altria's management and a Q&A session [Operator Instructions].

Altria Group, Inc. (MO) Q3 2022 Earnings Call Transcript

Altria (MO) delivered earnings and revenue surprises of -2.29% and 3.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Q3 Earnings and Revenues Miss Estimates

Japan Tobacco Inc

Marlboro maker Altria Group Inc on Thursday announced a strategic partnership with Japan Tobacco in an attempt to boost its smoke-free category.

Altria partners with Japan Tobacco to bolster smoke-free category

Altria also said it make an initial capital contribution of $150 million towards a new venture with Japan Tobacco called Horizon Innovations.

Tobacco Firm Altria Stock Falls After Missing Profit Estimates

Cigarette maker Altria Group narrowed its earnings guidance for the year as it reported third-quarter earnings and revenue that missed Wall Street estimates.

Altria quarterly earnings miss estimates as cigarette maker's revenue falls

Shares of Altria Group Inc. MO, +1.25% fell 0.2% in premarket trading Thursday, after the Marlboro cigarette and heated tobacco company missed earnings expectations, as elevated gas prices and high inflation weighed on spending trends by adult tobacco consumers (ATCs). The company swung to net income of $224 million, or 12 cents a share, from a loss of $2.72 billion, or $1.48 a share, in the year-ago period.

Altria misses profit and revenue expectations as inflation weighs on tobacco spending, stock slips

Altria Announces Election of Jacinto Hernandez to Altria's Board of Directors and Retirement of Board Member Leo Kiely

Marlboro maker Altria Group Inc. said it is forming a partnership with Japan Tobacco Group to develop and sell heated tobacco devices in the U.S. and abroad.

Altria takes on Juul, Philip Morris in smoke-free tobacco

Altria Reports 2022 Third-Quarter and Nine-Months Results; Narrows 2022 Full-Year Earnings Guidance

Altria Announces Strategic Partnership With JT Group and Expanded Heated Tobacco Portfolio

The Companies sign a strategic long-term global partnership in RRP  TOKYO , Oct. 27, 2022 /PRNewswire/ -- Japan Tobacco (JT) (TSE: 2914) announced today that the JT Group, through its subsidiary JTI, has entered into a joint venture (JV) with Altria Group (Altria), through its subsidiary PM USA, to market and commercialize heated tobacco sticks (HTS) products in the U.S. with Ploom branded devices and Marlboro branded consumables. The two Groups also signed a long-term, non-binding global memorandum of understanding (MOU) to explore commercial opportunities for a wide range of potentially reduced-risk products (RRP).

JT Group and Altria Group announce a joint venture to commercialize Ploom heated tobacco sticks products in the U.S.

Philip Morris

The Marlboro maker will invest $150 million in a joint venture with Japan Tobacco.

Altria to Take on Juul, Philip Morris in Smoke-Free Tobacco

Alico

Bolster your passive income with these high-yielders.

3 Safe Dividend Stocks Yielding Over 7%

While MO stock looks like it has some room for growth, it is helpful to see how Altria's Peers fares on metrics that matter.

How Will Altria Stock Trend Post Q3 Results?

Altria's (MO) third-quarter 2022 results are likely to reflect gains from pricing and strength in the oral tobacco products space, while cost inflation may have been a concern.

Altria's (MO) Q3 Earnings Upcoming: Key Factors to Note

Vape maker Juul looks for financing from Nick Pritzker and Riaz Valani, two billionaire investors, as the FDA and lawsuits edge the e-cigarette maker closer to bankruptcy.

Juul discusses a possible bailout with two of its biggest investors

Caterpillar

Cameco

McDonald's

The three major U.S. equity indexes closed higher on Monday after bouncing lower in the early going.

Earnings Previews: Altria, Cameco, Caterpillar, McDonald's

Which tobacco giant is the better bear market buy?

Better Buy: Altria vs. Philip Morris International

The tobacco stock is left with a diminished presence in the e-cig market.

Is Altria a Buy After Losing the Rights to IQOS?

V.F.

Viatris

Verizon

As you can see, I nibbled on several different positions earlier this month. Seeing some of these dividend stalwarts with yields way above their historical average was too much to ignore. Sure prices may continue to fall further but as a long time dividend investor I know that it is impossible to catch an absolute bottom.

Recent Stock Purchase October 2022

Juul Labs Inc. is in talks with two of its biggest investors on a bailout that could help the e-cigarette maker stave off a bankruptcy filing, according to people familiar with the matter.

Two of Juul's biggest investors may offer bailout to prevent bankruptcy

Juul Labs Inc is in talks with two of its investors about a bailout that could help it avoid a bankruptcy filing, the Wall Street Journal reported on Monday, citing people familiar with the matter.

Juul discusses possible bailout with two of its biggest investors - WSJ

Hyatt Hotels heir Nick Pritzker and California investor Riaz Valani are considering putting up money to cover the vaping company's operations and near-term legal liabilities, according to people familiar with the matter.

News for Altria Stock (MO)